News | Treatment Planning | September 12, 2022

RaySearch Laboratories AB (publ) announces that Sunnybrook Health Sciences Centre – Odette Cancer Centre in Toronto, Canada, has placed an order for RayStation treatment planning system

RaySearch Laboratories AB (publ) announces that Sunnybrook Health Sciences Centre – Odette Cancer Centre in Toronto, Canada, has placed an order for RayStation treatment planning system.

September 12, 2022 — Sunnybrook Health Sciences Centre, one of Canada’s largest hospitals, offers a highly specialized comprehensive cancer program and treats more than 7,000 cancer patients per year. The center is equipped with 13 linear accelerators. This is the first sale made in Ontario since a Master Purchase Agreement was signed with Ontario Health in the first quarter of 2022.

The agreement includes a complete configuration of RayStation to fully replace the hospital’s existing treatment planning systems. The total order value is approximately CAD 6.2 million (approximately SEK 51.1 million), whereof at least CAD 3.5 million (SEK 28.8 million) is expected to constitute revenue in the third quarter of 2022. This excludes post-warranty support services which will amount to an additional CAD 1.88 million (approximately SEK 15.4 million) over the next eight years. A 36-month warranty is included in the order.

Johan Löf, founder and CEO, RaySearch, said: “Canada has one of the world’s most advanced cancer care programs. RaySearch has many strong relationships with Canadian centers, both clinical and academic, and we are proud to see that also Sunnybrook has put their trust in us and our innovative software. We look forward to working with this large and well-known center to further advance cancer treatment.”

For more information: www.raysearchlabs.com


Related Content

News | Radiation Therapy

October 2, 2023 — A type of head and neck cancer predominantly diagnosed in people who reside in low- and middle-income ...

Time October 02, 2023
arrow
News | Radiation Oncology

October 2, 2023 — Two liquid biopsy tests that look for the presence of human papillomavirus (HPV) in the blood ...

Time October 02, 2023
arrow
News | Prostate Cancer

October 1, 2023 — The presence of a clinical navigator to act as a liaison between people with prostate cancer and the ...

Time October 01, 2023
arrow
News | ASTRO

October 1, 2023 — The 2023 Abstract Award winners have been announced by the American Society for Radiation Oncology ...

Time October 01, 2023
arrow
News | Women's Health

October 1, 2023 — In a first-of-its-kind study, people with breast cancer who underwent implant-based breast ...

Time October 01, 2023
arrow
News | Women's Health

October 1, 2023 — People who engage in sexual activity or vaginal dilation after chemoradiation treatment for cervical ...

Time October 01, 2023
arrow
News | Stereotactic Body Radiation Therapy (SBRT)

October 1, 2023 — Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted ...

Time October 01, 2023
arrow
News | Information Technology

September 29, 2023 — Fuse Oncology (Fuse) a trailblazing leader in radiation oncology software solutions, unveils their ...

Time September 29, 2023
arrow
News | Prostate Cancer

September 29, 2023 — People with intermediate risk, localized prostate cancer can be treated as effectively using fewer ...

Time September 29, 2023
arrow
News | Oncology Information Management Systems (OIMS)

September 29, 2023 — RaySearch will be showcasing the latest software innovations at ASTRO in San Diego, California ...

Time September 29, 2023
arrow
Subscribe Now